Bioinvent

BioInvent Regains Rights to Immuno-Oncology Targets from Exelixis
BioSpace
Fri, 01/12/24 - 09:40 am
Bioinvent
Exelixis
immuno-oncology
Merck to support Transgene and BioInvent led oncolytic virus clinical trial
Biopharma Reporter
Tue, 06/28/22 - 05:51 pm
Merck
Keytruda
clinical trials
Transgene
Bioinvent
solid tumors
ADC Space Continues to Thrive with Four More Companies Linking Up
BioSpace
Thu, 06/16/22 - 10:30 am
antibody-drug conjugate
Exelixis
Bioinvent
Oxford BioTherapeutics
Immunogen
Exelixis taps into cancer antibody discoverer out of Sweden
Endpoints
Thu, 06/16/22 - 10:28 am
Exelixis
Bioinvent
cancer
Sweden
immuno-oncology
BioInvent Presents Positive Preclinical Data for BI-505 in Myeloma
Pipeline Review
Sat, 02/28/09 - 12:21 pm
Bioinvent
Multiple Myeloma